Table 3 Changes in uric acid levels in female adults in quartiles of a new anthropometric indicator.

From: The effects and predictive values of novel anthropometric parameters on uric acid levels and hyperuricemia in adults

Variables

AIP

CMI

LAP

VAI

TyG

ABSI

BRI

Q1

251.77 ± 49.13

250.53 ± 47.70

249.46 ± 47.82

251.11 ± 48.63

250.41 ± 48.07

267.66 ± 55.17

254.88 ± 48.23

Q2

266.18 ± 51.24a

264.93 ± 50.61a

263.00 ± 48.09a

266.54 ± 51.56a

264.54 ± 50.54a

275.27 ± 57.32a

268.97 ± 53.75a

Q3

280.86 ± 57.37ab

281.46 ± 57.53ab

282.91 ± 57.95ab

280.17 ± 57.16ab

281.92 ± 56.37ab

278.57 ± 61.12a

280.28 ± 59.23ab

Q4

308.96 ± 66.16abc

310.83 ± 65.88abc

312.43 ± 65.56abc

309.94 ± 65.82abc

310.89 ± 66.49abc

286.25 ± 65.22abc

303.77 ± 67.08abc

F

236.96

270.86

307.85

249.75

274.76

20.94

163.26

P

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

  1. Data are expressed as mean ± standard deviation or median (IQR) for continuous variables.
  2. AIP atherogenic index of plasma, CMI cardiometabolic index, LAP lipid accumulation product, VAI visceral adiposity index, TyG index triglyceride glucose index, ABSI A body shape index, BRI body roundness index.
  3. aCompared with Q1 group. bCompared with Q2 group. cCompared with Q3 group.